Research Resumes at The Institute of Tumor Research

Getting our analysis fully ready to go again following the coronavirus lockdown had been a vital step regarding the ICR. Our staff and learners were desperate to access the job they love doing back again, generating the discoveries that defeat tumor.

Inside early June, we found the beginning of the gradual go back of ICR researchers to our laboratories following disruption brought on by coronavirus pandemic.

We had in no way been completely closed throughout the lockdown – a number of our labs remained lively, working for illustration on critical clinical demo samples or perhaps on Covid-19, and our computational scientists remained busy. But a lot of our research was at a standstill.

So it’s been great during the last 8 weeks to see the wind up of the variety of our researchers functioning at the bench, week and just about everyone has become back for at the least part the working.

Nik Matthews, Genomics office manager in the Tumour Profiling Unit, describes how he sensed about his come back to the bench: “It absolutely was a pleasure to have back in and boost the work back upwards, not for my own, personal sanity just, but for the truly amazing work my team really does at the ICR here.”

Working in consultation with your students and staff, a set originated by us of safety instructions across all our sites, alongside local rules for individual workspaces. The greatest changes range from the introduction of staggered working patterns, one-way systems and physical distancing rules – that are enabling us to allow for as many researchers as you can safely.

As our researchers attempt to conform to the ‘new normal’, some are feeling optimistic in regards to the future.

Erin Cutts, a postdoc in the Division of Structural Biology, says: “I’m getting excited about more flexibility in exactly how we work in future. To be able to are available in early or late and home based may help everyone balance work and life quicker, as well as assist in preventing labs from being over-crowded and equipment being overbooked!”

We’ve lost many vital research hours to the coronavirus crisis nevertheless the requirement for our work keeps growing. Please help us kick-start our research to produce up for lost amount of time in discovering smarter, kinder and much more effective cancer treatments, also to ensure cancer patients aren’t getting left behind.

Impact on our research

Although the pandemic has been disruptive to the work enormously, we have was able to continue our research in several areas, including our world-leading computational research in cancer genetics, evolution, drug discovery and clinical trials data.

But the lockdown period had a big affect our wet laboratories particularly. While our researchers did their utmost to dedicate their time for you to activities which can be done remotely, such as for instance writing papers, many were forced to place their vital experimental focus on hold for months. And for these projects, it’s not only a matter of switching everything back on because it will often make time to ramp things up again – as an example, to develop up cells in the mandatory volumes required for experiments.

This drive to obtain everything back installed and operating comes as funding for the research has declined through cuts in grants and the cancellation of major fundraising events. We must also finish equipping our Centre for Cancer Drug Discovery – an important new research building in Sutton, that will assemble 300 scientists to find out another generation of ‘anti-evolution’ cancer treatments

In a reaction to these challenges, we recently launched our major new fundraising attract help the ICR replace with the lost time and kick-start our life-saving research.

Our researchers are as passionate as about making the discoveries to defeat cancer ever. Nevertheless the coronavirus pandemic is a huge major setback because of their continued progress. Develop which our appeal will raise vital funds to simply help us compensate for the investigation hours they’ve lost.